A phase I clinical trial of carbon ion radiotherapy and concurrent gemcitabine
Phase 1
Recruiting
- Conditions
- Pancreatic Cancer
- Registration Number
- JPRN-UMIN000010120
- Lead Sponsor
- Research Center Hospital for Charged Particle Therapy National Institute of Radiological Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)History of abdominal radiotherapy 2)Metallic stent for obstructive jaundice 3)Digestive tracts invasion 4)Severe complicating illness 5)Histoly of other malignancies within 2 years 6)Active and Severe infection 7)medical, psychological or others reason that primary doctor think ineligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute toxicity of organ at risks
- Secondary Outcome Measures
Name Time Method Primary response rate by recommended dose in 6 months after treatment